These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 6764094)
1. [Statistical methods in the evaluation of the therapeutic efficacy--their problems and solutions]. Tominaga S Gan To Kagaku Ryoho; 1982 Nov; 9(11):1873-81. PubMed ID: 6764094 [TBL] [Abstract][Full Text] [Related]
2. [Comparative clinical trials]. Yokoyama M Gan To Kagaku Ryoho; 1984 Mar; 11(3):404-12. PubMed ID: 6703720 [TBL] [Abstract][Full Text] [Related]
3. Patient heterogeneity in clinical trials. Simon R Cancer Treat Rep; 1980; 64(2-3):405-10. PubMed ID: 7407777 [TBL] [Abstract][Full Text] [Related]
4. Clinical trials. How should they be designed? Onken JE; Brazer SR Gastrointest Endosc Clin N Am; 1994 Apr; 4(2):423-34. PubMed ID: 8193874 [TBL] [Abstract][Full Text] [Related]
5. [Analysis of the quality of clinical trials about therapeutic research using the standard of evidence-based medicine]. Chen F; Zeng YC; Wei HR Zhonghua Yan Ke Za Zhi; 2004 Sep; 40(9):609-13. PubMed ID: 15500766 [TBL] [Abstract][Full Text] [Related]
7. [Evaluation of using statistical methods in selected national medical journals]. Sych Z Ann Acad Med Stetin; 1996; 42():67-84. PubMed ID: 9199127 [TBL] [Abstract][Full Text] [Related]
8. [Critical analysis of a parallel group randomized trial]. Giraudeau B Rev Pneumol Clin; 2002 Nov; 58(5 Pt 1):261-7. PubMed ID: 12486375 [TBL] [Abstract][Full Text] [Related]
9. Randomized phase II designs in cancer clinical trials: current status and future directions. Lee JJ; Feng L J Clin Oncol; 2005 Jul; 23(19):4450-7. PubMed ID: 15994154 [TBL] [Abstract][Full Text] [Related]
10. Statistical considerations in drug trials of peptic ulcer. Elashoff JD J Clin Gastroenterol; 1981; 3(Suppl 2):135-40. PubMed ID: 7320463 [TBL] [Abstract][Full Text] [Related]
11. Cultural feasibility studies in preparation for clinical trials to reduce maternal-infant HIV transmission in Haiti. Coreil J; Losikoff P; Pincu R; Mayard G; Ruff AJ; Hausler HP; Desormeau J; Davis H; Boulos R; Halsey NA AIDS Educ Prev; 1998 Feb; 10(1):46-62. PubMed ID: 9505098 [TBL] [Abstract][Full Text] [Related]
12. [Use of prognostic knowledge in the planning and analysis of randomized therapeutic trials]. Byar D; Chastang C Bull Cancer; 1987; 74(2):177-84. PubMed ID: 3607300 [TBL] [Abstract][Full Text] [Related]
13. Can clinical trials requiring frequent participant contact be conducted over the Internet? Results from an online randomized controlled trial evaluating a topical ointment for herpes labialis. Formica M; Kabbara K; Clark R; McAlindon T J Med Internet Res; 2004 Feb; 6(1):e6. PubMed ID: 15111272 [TBL] [Abstract][Full Text] [Related]
15. [A tentative of guideline for phase III study and its problems in clinical aspect]. Nakao I Gan To Kagaku Ryoho; 1984 Mar; 11(3):395-403. PubMed ID: 6703719 [TBL] [Abstract][Full Text] [Related]
16. Designing and analyzing clinical trials which allow institutions to randomize patients to a subset of the treatments under study. Schoenfeld DA; Gelber RD Biometrics; 1979 Dec; 35(4):825-9. PubMed ID: 526527 [TBL] [Abstract][Full Text] [Related]
17. The journal impact factor as a predictor of trial quality and outcomes: cohort study of hepatobiliary randomized clinical trials. Gluud LL; Sørensen TI; Gøtzsche PC; Gluud C Am J Gastroenterol; 2005 Nov; 100(11):2431-5. PubMed ID: 16279896 [TBL] [Abstract][Full Text] [Related]
18. [Methodology of controlled clinical studies on the primary treatment of operable breast cancer]. Scheurlen H; Olschewski M; Leibbrand D Strahlentherapie; 1984 Aug; 160(8):459-68. PubMed ID: 6474519 [TBL] [Abstract][Full Text] [Related]